All-trans retinoic acid (ATRA)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 00:34, 26 February 2012 by PeterYang (talk | contribs)
Jump to navigation Jump to search

Also known as all-trans retinoic acid, or ATRA.

General information

Class/mechanism: Retinoid, induces maturation/differentiation of acute promyelocytic leukemia (APL) cells. Exact mechanism unknown.[1][2]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information[1].

Patient drug information

References

  1. ↑ 1.0 1.1 Tretinoin (Vesanoid) package insert
  2. ↑ Tretinoin (Vesanoid) package insert (locally hosted backup)
  3. ↑ Tretinoin (Vesanoid) patient drug information (Chemocare)
  4. ↑ Tretinoin (Vesanoid) patient drug information (UpToDate)
Retrieved from "https://hemonc.org/w/index.php?title=All-trans_retinoic_acid_(ATRA)&oldid=1051"